1. Home
  2. OVID vs UAC Comparison

OVID vs UAC Comparison

Compare OVID & UAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ovid Therapeutics Inc.

OVID

Ovid Therapeutics Inc.

HOLD

Current Price

$2.51

Market Cap

117.5M

Sector

Health Care

ML Signal

HOLD

UAC

United Acquisition Corp. I Class A Ordinary Shares

N/A

Current Price

$9.96

Market Cap

140.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
OVID
UAC
Founded
2014
2025
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
117.5M
140.2M
IPO Year
2017
2026

Fundamental Metrics

Financial Performance
Metric
OVID
UAC
Price
$2.51
$9.96
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$4.20
N/A
AVG Volume (30 Days)
3.1M
28.7K
Earning Date
03-18-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
3.90
N/A
EPS
N/A
N/A
Revenue
$7,252,000.00
N/A
Revenue This Year
$1,077.56
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1181.27
N/A
52 Week Low
$0.24
$9.51
52 Week High
$2.72
$9.95

Technical Indicators

Market Signals
Indicator
OVID
UAC
Relative Strength Index (RSI) 76.72 51.99
Support Level $1.31 $9.83
Resistance Level N/A N/A
Average True Range (ATR) 0.21 0.06
MACD 0.07 0.01
Stochastic Oscillator 82.11 100.00

Price Performance

Historical Comparison
OVID
UAC

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: